Penn Foundation
-
Services:
- Female
- Male
- Substance use disorder counseling
- Telemedicine/telehealth therapy
- Relapse prevention
- Trauma-related counseling
- Motivational interviewing
- Anger management
- Cognitive behavioral therapy
- 12-step facilitation
- Regular outpatient treatment
- Intensive outpatient treatment
- Outpatient methadone/buprenorphine or naltrexone treatment
- Outpatient
- Smoking permitted in designated area
- Social skills development
- Case management service
- No formal relationship with prescribing entity
- In-network prescribing entity
- Other contracted prescribing entity
- HIV or AIDS education, counseling, or support
- Group counseling
- Substance use disorder education
- Health education services other than HIV/AIDS or hepatitis
- Individual counseling
- Hepatitis education, counseling, or support
- Family counseling
- Screening for substance use
- Outreach to persons in the community
- Screening for mental disorders
- Comprehensive mental health assessment
- Comprehensive substance use assessment
- Interim services for clients
- State-financed health insurance plan other than Medicaid
- Private health insurance
- Medicaid
- Cash or self-payment
- Vaping not permitted
- Housing services
- Employment counseling or training
- Mentoring/peer support
- Assistance with obtaining social services
- Self-help groups
- Buprenorphine used in Treatment
- Naltrexone used in Treatment
- State Substance use treatment agency
- Sign language services for the deaf and hard of hearing
- Adults
- Young Adults
- Prescribes naltrexone
- Maintenance service with medically supervised withdrawal after stabilization
- Relapse prevention with naltrexone
- Prescribes buprenorphine
- Accepts clients using MAT but prescribed elsewhere
- Buprenorphine maintenance
- Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere
- This facility administers/prescribes medication for alcohol use disorder
- Breathalyzer or blood alcohol testing
- TB screening
- Drug and alcohol oral fluid testing
- Drug or alcohol urine screening
- In-network prescribing entity
- No formal relationship with prescribing entity
- Other contracted prescribing entity
- Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
- Substance use treatment
- Buprenorphine with naloxone
- Buprenorphine (extended-release, injectable)
- Medication for mental disorders
- Non-nicotine smoking/tobacco cessation
- Disulfiram
- Acamprosate (Campral®)
- Nicotine replacement
- Buprenorphine without naloxone
- Naltrexone (oral)
- Clonidine
- Naltrexone (extended-release, injectable)
- Private non-profit organization
- Discharge Planning
- Naloxone and overdose education
- Outcome follow-up after discharge
- Aftercare/continuing care
Gender Accepted
Treatment Approaches
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Facility Smoking Policy
Ancillary Services
External Opioid Medications Source
Education and Counseling Services
Assessment/Pre-treatment
Payment/Insurance/Funding Accepted
Facility Vaping Policy
Recovery Support Services
Opioid Medications used in Treatment
License/Certification/Accreditation
Language Services
Age Groups Accepted
Type of Opioid Treatment
Type of Alcohol Use Disorder Treatment
Testing
External Source of Medications Used for Alcohol Use Disorder Treatment
Type of Care
Pharmacotherapies
Facility Operation (e.g., Private, Public)
Transitional Services
